Login to Your Account

Osteotech Stock Jumps 63%

Eyeing Regenerative Medicine, Medtronic Acquires Osteotech

By Trista Morrison

Wednesday, August 18, 2010
Medical device maker Medtronic Inc. staked a deeper claim in the regenerative biologics field by moving to acquire Osteotech Inc. for $6.50 per share, or $123 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription